Graypoint LLC Acquires New Holdings in Quanterix Co. (NASDAQ:QTRX)

Graypoint LLC bought a new stake in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 65,000 shares of the company's stock, valued at approximately $691,000. Graypoint LLC owned about 0.17% of Quanterix as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of QTRX. Hsbc Holdings PLC raised its holdings in shares of Quanterix by 34.7% in the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company's stock worth $164,000 after buying an additional 3,279 shares during the period. Emerald Mutual Fund Advisers Trust increased its stake in Quanterix by 0.8% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company's stock worth $7,300,000 after purchasing an additional 4,406 shares during the period. nVerses Capital LLC purchased a new stake in Quanterix in the third quarter worth $60,000. Janney Capital Management LLC lifted its position in shares of Quanterix by 33.6% during the third quarter. Janney Capital Management LLC now owns 23,553 shares of the company's stock worth $305,000 after purchasing an additional 5,930 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Quanterix by 14.5% during the second quarter. American Century Companies Inc. now owns 56,145 shares of the company's stock valued at $742,000 after purchasing an additional 7,118 shares during the period. 86.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, TD Cowen lifted their price objective on shares of Quanterix from $13.50 to $16.00 and gave the company a "hold" rating in a report on Wednesday, November 13th.

Quanterix Price Performance

Shares of QTRX stock traded down $2.31 during mid-day trading on Friday, hitting $9.42. The stock had a trading volume of 2,617,056 shares, compared to its average volume of 713,307. Quanterix Co. has a 12-month low of $9.16 and a 12-month high of $29.70. The firm's 50-day moving average is $11.91 and its two-hundred day moving average is $12.66. The firm has a market capitalization of $362.90 million, a P/E ratio of -8.97 and a beta of 1.33.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.